Indian pharma companies like Dr Reddys, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.

Mumbai: Cipla has announced that Rajeev Kumar Sinha, Global Chief Manufacturing Officer and Senior Management Personnel of ...

Cipla's US sales are expected to be adversely impacted by price erosion and supply disruptions for tumor drug Lanreotide, ...

The S P BSE Sensex was up 204.76 points to 76,725.14 at 9:17 am, while the NSE Nify50 traded 64.15 points higher at 23,269.50 ...

Stay informed with the Cipla Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...

The market may remain in positive terrain amid elevated volatility. Below are some trading ideas for the near term.

Cipla said that the United States Food and Drugs Administration (US FDA) has issued one observation in Form 483 to the manufacturing facility of its wholly-owned subsidiary Medispray Laboratories.

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

Cipla share price has risen by 10% over the past 12 months and 64% over the last three years. The company's current market ...

Angel One, Bandhan Bank, Kalyan Jewellers, L&T Finance, Manappuram Finance, RBL Bank shares were banned from F&O trading on 21 January 2025.

Sensex and Nifty are set to open higher today, tracking firm cues from Asian markets and positive trend at Gift Nifty.

This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign ...